Researchers have identified the DAG peptide as a potential biomarker for Alzheimer’s disease development.
Three single-nucleotide polymorphisms have been identified as viable candidates as biomarkers for the personalized monitoring and treatment of lung cancers.
At Reid 2017 we interviewed Jennifer Hincks, Principal Scientist at LGC, about her role in setting up a new flow cytometry service. Jennifer discusses her passion for flow cytometry, how it can be used to analyze biomarkers and how this field can be regulated and standardized.
At Reid 2017 we interviewed James Rudge, Global Microsampling Specialist at Neoteryx, about his role in developing volumetric absorptive microsampling. James talks about his interest in biomarkers, what technologies he uses to analyze biomarkers and how he thinks the ‘omics’ field will come online.
In this review, the authors discuss the use of biomarkers as diagnostic tools for human primary membranous nephropathy. Learn more in this article from Biomarkers in Medicine.
Researchers have identified an alternative method to biopsies that could measure a patient’s response rate to immunotherapies utilizing the PD-1 pathway.
Challenges of single and multiplex biomarker validation on ‘planet Earth’ versus ‘planet Biomarkertopia’
Available to view on demand.
This presentation focuses on the current status and industry standards for Fit-for-Purpose biomarker assay validations.
Through metabolic fingerprinting researchers have identified specific compounds that could be utilized as biomarkers for smoking induced biological changes.
A recent metabolomics study has identified biomarkers from particular foods, which could help in establishing the connection between diet and Type 2 Diabetes, quantitatively.
Study identified blood-based biomarkers, which could be used alongside traditional methods to improve the diagnosis of sepsis.